By Akin Nazli in Belgrade Novartis (Zurich/NOVN) has stopped selling some of its pharmaceutical products in Turkey, Nilufer Gurpinar Guner, a communications director at Novartis’ Turkey unit, on January 23 confirmed in a statement to local daily Sozcu. The move is related to government exchange rate stipulations on payments made for pharmaceuticals amid the severe depreciation of the Turkish lira. Previously, on January 22, a document sent by Novartis Ilac Turkiye to pharmacists on the decision to cease sales was shared on social media. Novartis in this document informs pharmacists that it sto…